"Hearst Magazines and AOL may earn commission or revenue on some items through these links." Kidney disease, which affects one in seven Americans, is more than twice as common as coronary heart ...

April 21 (Reuters) - AstraZeneca said on Tuesday its rare blood disorder drug Ultomiris has met the main goal of a late-stage ...

Ultomiris demonstrated statistically significant and clinically meaningful reduction of proteinuria in adults with IgAN in I CAN phase III trial: Cambridge, UK Wednesday, April 22 ...

Bill Rosales had struggled for months to ask for help by the time he got a call from a high school friend. The Chicago ...

Already approved to treat four rare diseases, AstraZeneca’s Ultomiris has shown its ability against another rare disorder, ...

Positive high-level results from a prespecified interim analysis of the I CAN Phase III trial showed that Ultomiris (ravulizumab) met its primary ...

Travere Therapeutics TVTX shares surged 37.2% on Tuesday after the company announced that the FDA approved Filspari ...

Millions of people are suffering from hypertension worldwide, which may lead to several health issues, impacting different ...

The two were friends in high school before going their separate ways to become firefighters in Chicago and Bolingbrook.

At just 3 years old, a dog named Buddy has already lived through being the sole survivor in a house fire and diagnoses of ...

Researchers have found in a new research that even normal to mildly elevated total bilirubin (TBIL) levels are independently ...

Preeclampsia is a serious pregnancy disorder, affecting nearly 10 millionwomen globally each year, and can strike without ...